| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910793633803321 |
|
|
Autore |
Heeringa Heidi McMartin |
|
|
Titolo |
The visual brain and peripheral reading and writing disorders / / Heidi McMartin Heeringa |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Thorofare, New Jersey : , : Slack Incorporated, , [2019] |
|
©2019 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-63091-543-2 |
1-63091-542-4 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (131 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Visual perception |
Language disorders - Diagnosis |
Visual Perception |
Language Disorders - diagnosis |
Visual Pathways |
Language Disorders - therapy |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Sommario/riassunto |
|
"The Visual Brain and Peripheral Reading and Writing Disorders: A Guide to Visual System Dysfunction for Speech-Language Pathologists familiarizes the reader with the complex workings of the human visual system, the motor and sensory components of normal vision as they relate to the recognition of letters and words, and to the acquisition and rehabilitation of reading and writing. This text brings together findings from the neuropsychological, neurooptometric, neurolinguistic, occupational therapy, and speech-language pathology literature on acquired visual system impairment from the past 20+ years, and the ways visual system dysfunction impacts reading, writing, and cognition. Chapters Include: - Review of structural elements of the eye, the cortical and subcortical structures of the visual brain, and the motor and sensory components of normal vision - The distinct functions of the three primary visual pathways (central, peripheral and |
|
|
|
|
|
|
|
|
|
|
|
|
|
retinotectal) and how they relate to reading and writing - Review of five formal tests of reading and writing that are designed or may be adapted to assess peripheral reading and writing disorders - And much more!"-- |
|
|
|
|
|
|
2. |
Record Nr. |
UNISA996575323103316 |
|
|
Titolo |
3207-2022 - IEEE Standard for Blockchain-Based Digital Asset Identification / / Institute of Electrical and Electronics Engineers |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York : , : IEEE, , 2023 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (32 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Sommario/riassunto |
|
The data fields, types, and formats related to digital assets to improve digital asset identification efficiency are defined by this standard. Moreover, guidance for blockchain-based digital asset identification is provided by the definition and description of methods and data structures in this standard. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910557359303321 |
|
|
Autore |
L. Pouliquen Daniel |
|
|
Titolo |
Malignant Mesothelioma |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (328 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos. Although this mineral has been banned for decades in many countries, epidemiologists predict the MM epidemic will last past 2040, raising many concerns in public health given its late diagnosis, dismal prognosis, and lack of current efficient therapies.To deal with this situation, important breakthroughs have recently been made in the understanding of MM's complex biology and the carcinogenic process of the different patterns of the disease. Examples of these include the development of new biomarkers and the deciphering of gene-environment interactions, molecular mechanisms of invasiveness, deregulated pathways, altered expression of miRNAs, DNA damage repair, or metabolic profile. From now on, MM's aggressive and chemoresistant character appears linked to a polyclonal malignancy, and heterogeneity in molecular alterations.Given these improvements, new therapeutic targets are being explored to solve the double challenge faced by clinicians. The first is to reduce tumor development and its wasting consequences as soon as possible, without resistance and with limited toxicity. The second is to stimulate the recognition of tumor cells by the induction of a specific immune response. This Special Issue will highlight all these aspects. |
|
|
|
|
|
|
|
| |